Anti-HIV lectins represent a promising class of naturally derived biomolecules that interrupt early stages of HIV infection through targeted carbohydrate recognition. These lectins bind selectively to ...
A memo regarding HIV treatment and prevention, issued by the State Department on February 6, offers a stark illustration of the impact of the Trump administration on global health. One section of the ...
As one of the most influential and successful actions in the global fight against AIDS, PEPFAR — short for the President’s Emergency Plan for AIDS Relief — long enjoyed the rarified air of bipartisan ...
A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho University, in collaboration with the Duke University Medical Center in the ...
AIDS prevention got a boost last year when researchers reported that the daily combination anti-HIV pill Truvada, which is designed to treat the disease, may actually be able to prevent HIV infection ...
Daily Maverick on MSN
Bringing it home: SA leads the charge to make anti-HIV jab for Africa
South Africa’s National Aids Council has launched a renewed effort to secure licences to make generic versions of lenacapavir ...
Predictive values may be defined as the likelihood that a result is correct. Predictive values depend on prevalence of the target analyte. NPVs of HIV tests and testing strategies are always high even ...
Canonsburg, Pa.-based Mylan argues the U.S. is wasting billions of dollars on name brand anti-HIV drugs, instead of making generic alternatives, according to Science. At the International AIDS ...
Nigerians are scrambling for Lenacapavir, a new anti-HIV injection for prevention. Learn about this twice-yearly PrEP drug ...
On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the... Nearly all global health funding from the U.S. has ...
Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission a study led by the University of North Carolina at Chapel Hill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results